T cell receptor alpha variable 5 (TRAV5)

T cell receptor alpha variable 5 (TRAV5) encodes the variable domain of the alpha chain of the T cell receptor, which is expressed on T lymphocytes as part of the αβ TCR complex[1][3]. This variable region is generated by somatic DNA recombination, enabling immense diversity in antigen recognition. TRAV5 participates in the identification of peptide antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells, catalyzing intracellular signaling events that drive T cell activation, immune response, and adaptive immunity. While rarely targeted directly by drugs, its expression and usage are pivotal in immune monitoring and may be manipulated in advanced immunotherapies[1][3][4].

Other names

TRAV5TCRAV15S1TCRAV5S1

Drugs targeting the TCR complex commonly inhibit or modulate signal transduction cascades initiated by TCR–antigen/MHC engagement (e.g., inhibition of calcineurin pathway, kinase activity suppression)